过敏性结膜炎的CiteSpace可视化分析研究

Visual analysis of allergic conjuctivitis with CiteSpace

目的通过CiteSpace 6.2.R4软件进行分析,对国内过敏性结膜炎治疗进行研究。方法系统检索中国知网(CNKI)数据库中关于过敏性结膜炎治疗的相关研究文献并按照标准进行筛选,运用文献计量学及CiteSpace 6.2.R4软件可视化分析筛选出文献的作者,关键词及研究机构等内容。结果经过检索筛选,共纳入中文文献199篇,涉及223所机构和295位作者,部分作者之间的合作关系较为紧密,且形成相对稳定的核心研究团队共17个。年度发文量自2011年开始呈增长趋势,关键词中≥15次的高频词为奥洛他定、普拉洛芬、临床疗效、氯雷他定和疗效。结论该领域的研究热点主要集中在观察奥洛他定等药物对过敏性结膜炎治疗的临床效果上,2019-2020年的趋势转向中西医联合治疗,并在疗效和安全性的前提下,对新治疗方法的尝试的趋势增加。

Objective By using CiteSpace 6.2.R4,to perform a visual analysis of allergic conjuctivitis in China.Methods By searching and refining the literature from China Knowledge(CNKI)on the subject of curing the allergic conjuctivitis,with the help of tools from both CiteSpace 6.2.R4 and Bibliometrics,the author,keyword and Institutes will be visualized from the literature.Results By searching and refining,199 Chinese literature sources were adopted,involving 223 institutes and 295 authors,some authors are highly co-related,and 17 research core teams are formed by such relationships.From the year 2011,the amount of literature is growing annually,the top key words,which appears no less than 15 times,are olopatadine、pranoprofen、effectiveness、loratadine and effect.Conclusion Research trends are mainly focused on olopatadine’s effect on allergic conjuctivitis,the trends of 2019 to 2020 shifted to the combination with Chinese and Western medicine,by insuring the effectiveness and safety,the trends of using new therapy is increased.